Akt Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-Akt antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityAkt
Clonepolyclonal
Host SpeciesRabbit
Reactive Specieshuman, mouse, rat
Isotypen/a
FormatProtein A purified
Size0.05 mg, 0.2 mg
Concentrationn/a
ApplicationsImmmunohistochemistry (IHC) (PS), Immunoprecipitation (IP), Western Blot (WB)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionRecognizes human, mouse and rat Akt. Detects a band of ~59kDa by Western blot. The Akt (PKB) family of protein kinases are serine/threonine kinases, with three mammalian family members identified (Akt1, Akt2, Akt3). Akt is a well-characterized member of PI3 kinase-mediated signaling pathways, regulating cell growth, apoptosis, glycogen synthesis, and other cellular responses through its phosphorylation of downstream substrates. Akt activation is triggered by binding of phospholipid and phosphorylation at two key residues: Thr308 by PDK1, and Ser473 by PDK2, now identified as mTOR. Deregulation of Akt signaling has been associated with cancer, diabetes, and schizophrenia. Akt1 is the cellular homologue of the murine thymoma retroviral oncoge
ImmunogenImmunogen: Synthetic peptide corresponding to a portion of human Akt. The sequence is completely conserved in rat and bovine.
Other Names[Akt], [AKT1; AKT1; AKT; PKB; RAC; CWS6; PRKBA; PKB-ALPHA; RAC-ALPHA; PKB; RAC; PKB; PKB alpha]
Gene, Accession #[PKB; Protein kinase B; RAC], Gene ID: 207, NCBI: P31749.2, UniProt: P31749
Catalog #MBS565317
Price$250, $460
Order / More InfoAkt Antibody from MYBIOSOURCE INC.
Product Specific Referencesn/a
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.